Skip to main content
. 2022 Nov 10;6(12):910–914. doi: 10.1002/jgh3.12841

Table 2.

Adjusted odds ratio of various adverse outcomes in patients with inflammatory bowel disease on chronic corticosteroid therapy compared with those not on chronic corticosteroid therapy

Patients with inflammatory bowel disease and steroid use (n = 18 030)
Side effects Odds ratio P‐value Confidence interval
Osteoporosis 1.91 <0.001 1.77–2.05
Other bone disorders 1.27 0.271 0.83–1.92
Opportunistic infections 2.09 <0.001 1.80–2.41
Sepsis 0.94 0.252 0.84–1.05
Acute thrombotic event 1.48 <0.001 1.34–1.64
Transient ischemic attack 0.94 0.830 0.55–1.61
Cerebrovascular accident 0.82 0.156 0.63–1.08
Myocardial infarction 0.97 0.719 0.81–1.16
Diabetes mellitus 0.93 0.007 0.88–0.98
Cushing's syndrome 10.35 <0.001 7.29–14.67
Adrenal insufficiency 8.59 <0.001 6.96–10.62
Metabolic syndrome 0.99 0.958 0.96–1.03
Acute pancreatitis 0.73 0.002 0.61–0.89
Mood disorders 1.03 0.129 0.99–1.08
Drug‐induced cataract 2.98 0.349 0.30–29.34
Mortality 0.86 0.049 0.74–0.99